ELIC — Elicera Therapeutics AB Share News
0.000.00%
Last trade - 00:00- SEK199.54m
- SEK141.41m
- SEK10.86m
Brief: Elicera Gives Update On Carma Study
Brief: Elicera Therapeutics Q1 Operating Loss Widens To SEK 8.1 Mln
Brief: Elicera Therapeutics Resolves On Directed Issue Of Over 1.5 Mln Shares
Brief: Elicera Therapeutics Gets Partial Payment Of EUR 500,000 From EIC
Brief: Elicera Therapeutics Q4 Oper Loss Narrows To SEK 2.9 Mln
Brief: Elicera Therapeutics Q4 Dividend SEK 0
Brief: Elicera Therapeutics Drug Candidate Gets Orphan Drug Designation In U.S.
Brief: Elicera Therapeutics Q2 Operating Loss Widens To Sek 5.8 Mln
Brief: Elicera To Receive SEK 27.6 Mln Through Completed Rights Issue
Brief: Elicera Enters Agreement With Prominent US Cancer Center
Brief: Elicera Therapeutics Q4 EPS SEK -0.24
Brief: Elicera Therapeutics Proposes Dividend Of SEK 0.00 Per Share
Brief: Elicera Therapeutics Gets Approval To Initiate Clinical Phase I/II-Study CARMA
Brief: Elicera Proposes Rights Issue Of Units Of SEK 64 Mln
Founder Receives Grant Of SEK 4.8 Mln
Brief: Elicera Therapeutics Q3 Operating Loss Narrows To SEK 5.1 Million
Brief: Elicera Therapeutics Q3 Adjusted EPS SEK -0.16
Brief: Elicera Therapeutics Receives Allowance For Chinese Patent
Brief: Elicera Therapeutics Q2 Operating Loss Widens To SEK 4.5 Mln